• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
YAN Lixin.Observation on the effect of levosimendan in elderly patients with refractory systolic heart failure[J].Journal Of Pharmaceutical Research,2017,36(7):420-422[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3836times   Download 2953次 QR Code for this article
Scan with your phone!
左西孟旦在老年顽固收缩性心力衰竭患者中的疗效观察
闫立新
Font:Larger+|Default|Smaller-
(莱芜市新汶矿业集团莱芜中心医院,山东 莱芜 271103)
摘要:
目的 分析左西孟旦对老年顽固收缩性心力衰竭患者的疗效。方法 对128例符合纳入标准的心力衰竭患者入院初期应用常规药物洗脱治疗1周,1周后选取其中38例顽固性心力衰竭患者,按随机化原则分为对照组和治疗组各19例,对照组继续给予常规治疗,而治疗组在常规治疗基础上加左西孟旦治疗。比较两组治疗效果。结果 治疗组NYHA、LVEF及NT-proBN与对照组比较显著改善,差异有统计学意义(P<0.05);对照组应用左西孟旦后无低血压、心律失常和过敏发生,患者耐受性良好。结论 左西孟旦对老年顽固收缩性心功能不全患者有明显的疗效,且有较好的安全性和耐受性。
关键词:  左西孟旦  老年 心力衰竭
DOI:10.13506/j.cnki.jpr.2017.07.014
基金项目:
Publication Date:July 25, 2017
Observation on the effect of levosimendan in elderly patients with refractory systolic heart failure
YAN Lixin
(Laiwu Central Hospital of Xinwen Mining Group,Laiwu 271103,China)
Abstract:
Objective To analyze the effect of levosimendan on elderly patients with refractory systolic heart failure.Methods A total of 128 patients with heart failure who met the inclusion criteria were treated with conventional drug eluting therapy for 1 weeks at the initial stage of admission.One week later,38 patients with intractable heart failure were selected.They were divided into control group and treatment group according to the principle of randomization,each with 19 cases.The control group continued to be given conventional treatment,while the treatment group was treated with levosimendan on the basis of conventional treatment.The therapeutic effects of the two groups were compared.Results Compared with the control group,NYHA,LVEF and NT-proBN of treatment group were significantly improved,and the difference was statistically significant (P<0.05).The control group received levosimendan without hypotension,arrhythmia and hypersensitivity, and the patients were well tolerated.Conclusion Levosimendan was effective in the treatment of elderly patients with refractory systolic heart failure,and had better safety and tolerability.
Key words:  Levosimendan  Elderly  Heart failure
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.